Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-muscle-invasive Bladder Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02307487
What this trial is testing

Safety of Pre-TURBT Intravesical Instillation of Escalating Doses of TC-3 Gel and MMC in NMIBC Patients

Who this might be right for
Bladder CancerNeoplasmsUrinary Bladder Diseases+1 more
UroGen Pharma Ltd. 14
Not applicableStudy completedNCT07347132
What this trial is testing

Comparison of Pathological Outcome and Recurrence Rate Between En Bloc and Conventional Transurethral Resection of Bladder Tumor

Who this might be right for
Urinary Bladder NeoplasmsNon-muscle Invasive Bladder Cancer
Lahore General Hospital 116
Testing effectiveness (Phase 2)Study completedNCT00191711
What this trial is testing

Intravesical Gemcitabine Instillation Followed by Transurethral Resection for the Treatment of Patients With Superficial Bladder Cancer at Low Risk.

Who this might be right for
Superficial Bladder Cancer
Eli Lilly and Company 43
Not applicableLooking for participantsNCT07144319
What this trial is testing

Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy

Who this might be right for
Bladder CancerNon-muscle Invasive Bladder Cancer
Photocure 500
Not applicableEnded earlyNCT01314664
What this trial is testing

A Prospective Registry to Assess the Effectiveness and Local Tolerability of Intravesical Valrubicin in Subjects With Non-muscle Invasive Bladder Cancer (NMIBC)

Who this might be right for
Bladder CancerCIS
Endo USA Inc., a Keenova Therapeutics Company 15
Not applicableStudy completedNCT06235853
What this trial is testing

Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder CancerCystoscopyRecurrence+3 more
Wroclaw Medical University 240
Testing effectiveness (Phase 2)Looking for participantsNCT07646145
What this trial is testing

Disitamab Vedotin Plus Intravesical Mitomycin C in HER2-Expressing Intermediate- to High-Risk Non-Muscle-Invasive Bladder Cancer

Who this might be right for
Non-Muscle-Invasive Bladder Cancer (NMIBC)
Shanxi Province Cancer Hospital 30
Very early researchWithdrawnNCT05395260
What this trial is testing

FL- 101 Study in Non-Metastatic MIBC

Who this might be right for
Muscle Invasive Bladder Carcinoma
Flame Biosciences
Not applicableLooking for participantsNCT06990061
What this trial is testing

Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer: an Open-label, Single-arm, Multicentre, Phase 2 Study

Who this might be right for
Non-Muscle Invasive Bladder Cancer
European Organisation for Research and Treatment of Cancer - EORTC 50
Large-scale testing (Phase 3)Study completedNCT01920269
What this trial is testing

Intravesical Adjuvant Electromotive Mitomycin-C

Who this might be right for
Bladder Cancer TNM Staging Primary Tumor (T) TaBladder Cancer TNM Staging Primary Tumor (T) T1Bladder Cancer Transitional Cell Grade
University of Rome Tor Vergata 331
Large-scale testing (Phase 3)WithdrawnNCT07313891
What this trial is testing

Adjuvant NDV-01 (Sustained-release Gemcitabine-docetaxel) for the Treatment of Intermediate Risk NMIBC Following TURBT

Who this might be right for
Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive)Bladder (Urothelial, Transitional Cell) CancerUrothelial Carcinoma Bladder+1 more
Relmada Therapeutics, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT07747740
What this trial is testing

Sequential Gemcitabine Plus Docetaxel Versus Gemcitabine Plus Mitomycin C for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer

Who this might be right for
Non-Muscle-Invasive Bladder CancerBCG-Unresponsive Bladder Cancer
Blokhin's Russian Cancer Research Center 228
Early research (Phase 1)WithdrawnNCT05259397
What this trial is testing

PF-07225570 Alone or in Combination With an Anti-PD-1 Antibody in Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)

Who this might be right for
Bladder Cancer
Pfizer
Not applicableStudy completedNCT05945108
What this trial is testing

Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER

Who this might be right for
Urothelial CarcinomaNon Muscle Invasive Bladder CancerMuscle-invasive Bladder Cancer
AstraZeneca 400
Not applicableLooking for participantsNCT05337397
What this trial is testing

Outpatient Laser Ablation of Recurrent Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-Muscle Invasive Bladder Cancer
Jørgen Bjerggaard Jensen 145
Large-scale testing (Phase 3)Looking for participantsNCT06919965
What this trial is testing

Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer

Who this might be right for
Non-Muscle Invasive Bladder Neoplasms
Janssen Research & Development, LLC 220
Not applicableAvailableNCT06443944
What this trial is testing

An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG

Who this might be right for
Non-Muscle Invasive Bladder CancerUrothelial CarcinomaUrologic Cancer+1 more
CG Oncology, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT05943379
What this trial is testing

RC48-ADC in Combination With Gemcitabine in High Risk NMIBC Subjects

Who this might be right for
NMIBC
RemeGen Co., Ltd. 85
Testing effectiveness (Phase 2)Ended earlyNCT03549650
What this trial is testing

Prevention and Management of Intravesical BCG-related Lower Urinary Tract Symptoms

Who this might be right for
Lower Urinary Tract SymptomsBladder CarcinomaBCG
Sir Mortimer B. Davis - Jewish General Hospital 3
Not applicableUnknownNCT05864599
What this trial is testing

External Validation of Uromonitor as a Biomarker for Optimization of NMIBC Management by the CUETO Group

Who this might be right for
Non-muscle-invasive Bladder Cancer
Pharmalink 600
Next Page